Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What Are the Long-Term Prospects for Moderna?


There's no question that Moderna (NASDAQ: MRNA) is about to have a very good year financially. The biotech has major supply deals lined up for its COVID-19 vaccine and is hard at work cranking out millions of doses. But what are Moderna's long-term prospects? In this Motley Fool Live video recorded on Feb. 10, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss how Moderna might fare going forward.

Continue reading


Source Fool.com

Like: 0
Share

Comments